Singleron launches single cell eQTL analysis as part of their sequencing service
A new bioinformatic pipeline to investigate single cell eQTL analysis is now offered in the sequencing service from Singleron Biotechnologies. COLOGNE, Germany, Jan. 25, 2023 /PRNewswire/ -- Bioinformatic experts at Singleron Biotechnologies, a leader in single cell sequencing, have developed a new single cell eQTL analysis workflow that takes advantage of single cell RNA sequencing (scRNAseq) and whole genome sequencing...
DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease
Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of life, and pain medication usage out to two years post-injection in patients with lumbar DDD. SALT LAKE CITY, Jan. 25, 2023 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused...
Amcor to report Half Year 2023 results
ZURICH, Jan. 25, 2023 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its Half Year 2023 results for the six months ended 31 December 2022 after the US market closes on Tuesday 7 February 2023. A conference call and webcast to discuss the results will be held at 5.30pm US Eastern Standard Time on Tuesday 7 ...
Metabolon Secures $25 Million of Funding to Accelerate Growth
MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today announced that it has closed on $25 million of additional equity funding. The proceeds will be used for general corporate...
Complete Genomics to Announce New Product Launches at AGBT General Meeting
SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"), today announced it plans to launch three new products at the Advances in Genome Biology and Technology (AGBT) General Meeting on February 6-9 in Hollywood, Florida. The Company will launch an ultra-high-speed sequencer with...
Strava Acquires Outdoor Adventure Platform, FATMAP
The subscription platform continues to deliver a best-in-class digital experience meant to inspire and motivate their active community with the addition of FATMAP's 3D mapping technology making outdoor adventures easier to discover, experience and share SAN FRANCISCO, Jan. 24, 2023 /PRNewswire/ -- Strava, the subscription platform at the center of connected fitness, announced the acquisition of FATMAP,...
2023 Japan Prize Laureates Announced
TOKYO, Jan. 24, 2023 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2023 Japan Prize on January 24, 2023. Prof. Masataka Nakazawa and Mr. Kazuo Hagimoto, both of Japan, are co-winners of the Japan Prize in the fields of Electronics, Information, and Communication, and Prof. Gero Miesenboeck of Austria and Prof. Karl Deisseroth of the United States...
South Australia’s health system and The Clinician partner to deliver State-wide Patient Reported Measures Program
South Australia's Commission on Excellence and Innovation in Health and SA Health have partnered with The Clinician to implement a digital solution for the state-wide collection and analysis of patient reported outcome and experience measures (PROMs and PREMs). ADELAIDE, Australia, Jan. 24, 2023 /PRNewswire/ -- South Australia's Commission on Excellence and Innovation in...
ACCEPTANCE PERIOD FOR EXCHANGE OFFER EXTENDED PENDING COMPETITION CLEARANCES
THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS This is a joint press release by Koninklijke DSM N.V. (DSM),...
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal and brain tumors. Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a...
